Effectiveness of the low-level laser therapy in the management of bisphosphonate-induced osteonecrosis of the jaws: A case report

Authors

DOI:

https://doi.org/10.33448/rsd-v10i6.15199

Keywords:

Osteonecrosis; Bisphosphonates; Laser therapy; Treatment.

Abstract

The aim of this study was to report a clinical case of osteonecrosis caused by bisphosphonates and its treatment with the aid of laser therapy. Low-level laser therapy (LLLT) is a resource used that is characterized by photobiostimulation and photobiomodulation, promoting analgesia and anti-inflammatory effects and can also be a tool for treating osteonecrosis induced by bisphosphonates (BFs), when associated also to drug therapy. The present case is a 63-year-old patient, leukoderma, with thyroid disorder and osteoporosis, making continuous use of medicaments classified as BF’s. He had a dental fracture and sensitivity to cold and treatment started with prophylaxis. After radiography of the dental elements, restorations were performed and tooth extraction (element 46). In the postoperative period, the patient reports pain and a bone exposure were observed clinically in the region of the extracted area, with osteonecrosis being diagnosed. Drug therapy was promptly applied and the use of LLLT was chosen as an adjunctive and supportive therapy. It is plausible to infer the need for attention to patients undergoing drug treatment with bisphosphonates, fully evaluating the best treatment for the possible occurrence of osteonecrosis in view of LLT as an effective complementary therapeutic approach.

References

Altay, M., A., Tasar, F., Tosun, E., Kan, B. (2014) Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: a retrospective analysis of 11 cases. Photomed Laser Surg. 32(8):468-75.

Aragon-Ching, J. B., Ning, Y. M., Chen, C. C., Latham, L., Guadagnini, J. P., Gulley, J. L., Arlen, P. M., Wright, J. J., Parnes, H., Figg, W. D., & Dahut, W. L. (2009). Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents. Cancer investigation, 27(2), 221–226.

Brozoski, M. A., Traina, A, A, Deboni, M. C. Z., Marques, M. M., & Naclério-Homem, M. G. (2012). Osteonecrose maxilar associada ao uso de bisfosfonatos. Revista Brasileira de Reumatologia, 52(2), 265-270.

Cândido, E.L., Ribeiro, T. R.G., Brito, M.A.F., Rodrigues, S.B., Feitosa, M.D.S., Feitosa, F.P.J., & Freitas, J.F. (2021). Aspectos éticos e trâmites da publicação de relato de caso no Brasil. Research, Socity and Development, 10 (2), 1-5.

Cremers, S., Drake, M. T., Ebetino, F. H., Bilezikian, J. P., & Russell, R. (2019). Pharmacology of bisphosphonates. British journal of clinical pharmacology, 85(6), 1052–1062.

de Medeiros, M. L., Araújo-Filho, I., da Silva, E. M., de Sousa Queiroz, W. S., Soares, C. D., de Carvalho, M. G., & Maciel, M. A. (2017). Effect of low-level laser therapy on angiogenesis and matrix metalloproteinase-2 immunoexpression in wound repair. Lasers in medical science, 32(1), 35–43.

Enwemeka, C., S., Parker, J., C., Dowdy D., S., Harkness, E., E., Sanford L., E., Woodruff L., D. (2004) The efficacy of low-power lasers in tissue repair and pain control: a meta-analysis study. Photomed Laser Surg. 22(4):323-9.

Ervolino, E., Statkievicz, C., Toro, L. F., de Mello-Neto, J. M., Cavazana, T. P., Issa, J., Dornelles, R., de Almeida, J. M., Nagata, M., Okamoto, R., Casatti, C. A., Garcia, V. G., & Theodoro, L. H. (2019). Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate. Bone, 120, 101–113.

Favus MJ. Bisphosphonates for osteoporosis. N Engl J Med. 363(21):2027-35.

Hellstein, J. W., & Marek, C. L. (2005). Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 63(5), 682–689.

Khan, A., Morrison, A., Cheung, A., Hashem, W., & Compston, J. (2016). Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 27(3), 853–859.

Lee J. Y., Kim I. R., Park B. S., Kim Y. D., Chung I. K., Song J. M., &Shin S. H. (2005). Effect of low-level laser therapy on oral keratinocytes exposed to bisphosphonate. Lasers Med Sci, 30(2), 635-43.

Luke, A. M., Mathew, S., Altawash, M. M., & Madan, B. M. (2019). Lasers: A Review with their applications in oral medicine. Journal of lasers in medical sciences, 10(4), 324–329.

Madrid, C., & Sanz, M. (2009). What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clinical oral implants research, 20 Suppl 4, 87–95.

Mauceri, R., Panzarella, V., Maniscalco, L., Bedogni, A., Licata, M. E., Albanese, A., & Campisi, G. (2018). Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study. BioMed Research International, 2018, 1–10.

Neves, M., Gano, L., Pereira, N., Costa, M. C., Costa, M. R., Chandia, M., Rosado, M., & Fausto, R. (2002). Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies. Nuclear medicine and biology, 29(3), 329–338.

Nunes, T. P., Nunes, L. P., Silva, A. N. A., Pirovani, B. O., Morábito, M. J. S. D., de Morais, L.A., Gruba, A. S., & Nunes, G. P. (2021). Effects adverse of treatment with selective inhibitors of serotonin recaptation on the fetus and neonatals of mothers with gestational depression: A critical review. Research, Society and Development, 10(4), e11210413937.

Pereira, AS et al. (2018). Metodologia da pesquisa científica. UFSM.

Reid, I. R., Bolland, M. J., & Grey, A. B. (2007). Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone, 41(3), 318–320.

Rodriguez, A. C., Silva, C. E. X. S. R., Costa, D. M., Martins, M., Oliveira, V., Neto, R. M. S., … Chavantes, M. C. (2019). Low level laser therapy as coadjuvant in bisphosphonate related osteonecrosis of the jaws: a pilot study. International Journal of Oral and Maxillofacial Surgery, 48, 103

Rogers M. J. (2003). New insights into the molecular mechanisms of action of bisphosphonates. Current pharmaceutical design, 9(32), 2643–2658.

Romeo, U., Galanakis, A., Marias, C., Vecchio, A. D., Tenore, G., Palaia, G., Vescovi, P., & Polimeni, A. (2011). Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. Photomedicine and laser surgery, 29(7), 447–452.

Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., O'Ryan, F., & American Association of Oral and Maxillofacial Surgeons (2014). American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 72(10), 1938–1956.

Sánchez, M., D., P., R., Statkievicz, C., de Mello-Neto, J. M., Toro, L. F., Bassi, A., Garcia, V. G., Theodoro, L. H., & Ervolino, E. (2020). The Effectiveness of the Low-Level Laser, Antibiotic and Surgical Therapy in the Treatment of Medication-Related Osteonecrosis of the Jaws: A Case Report. Journal of lasers in medical sciences, 11(1), 98–103.

Sedghizadeh, P. P., Sun, S., Jones, A. C., Sodagar, E., Cherian, P., Chen, C., Junka, A. F., Neighbors, J. D., McKenna, C. E., Russell, R., & Ebetino, F. H. (2021). Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications. Bone, 147, 115933. Advance online publication.

Torres, A. A., de Freitas, B. L., Carneiro, P. P., de Sousa, A., Arêa Leão Ferraz, M. Â., de Pinho Mendes, J., Costa, A., & Pinto, A. (2020). Medication-Related Osteonecrosis of the Jaw and Low-Level Laser Therapy as Adjuvant Treatment: A Case Report. Journal of lasers in medical sciences, 11(4), 497–499.

Vescovi, P., Merigo, E., Meleti, M., Manfredi, M., Fornaini, C., Nammour, S., et al. (2014). Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw. Int J Dent. 2014.

Weber, J. B., Camilotti, R. S., & Ponte, M. E. (2016). Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review. Lasers in medical science, 31(6), 1261–1272.

Downloads

Published

24/05/2021

How to Cite

SILVA-SOUZA, L. G. da .; OLIVEIRA, L. D. de .; NUNES, G. P.; CIVIDANES, L. dos S. .; DAHAN, C. M. .; PEREIRA, A. K. G. .; KITAKAWA, D.; NEDER, V. M. .; CARVALHO, L. F. das C. e S. de . Effectiveness of the low-level laser therapy in the management of bisphosphonate-induced osteonecrosis of the jaws: A case report. Research, Society and Development, [S. l.], v. 10, n. 6, p. e17510615199, 2021. DOI: 10.33448/rsd-v10i6.15199. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/15199. Acesso em: 15 jun. 2021.

Issue

Section

Health Sciences